Welcome
Support Centre
07 August 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A Pilot Study of Continuous Negative Pressure (CNEP) In Bronchiolitis
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN53796751
Date ISRCTN assigned05/03/2004
Local reference number(s)N/A
Public titleA Pilot Study of Continuous Negative Pressure (CNEP) In Bronchiolitis
Scientific title
AcronymN/A
Disease/condition/study domainBronchiolitis
Study hypothesisNot provided at time of registration
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaForty two infants admitted with bronchiolitis, who needed more than 40% oxygen therapy to maintain normal levels of arterial oxygen saturation. This was a pilot study. Forty two patients were enrolled between January 1991 and April 1992 in two paediatric hospitals in England (North Staffordshire Hospital and Royal Berkshire Hospital) if they fulfilled the following criteria:
1. Clinical diagnosis of bronchiolitis (irrespective of whether respiratory syncitial virus was isolated)
2. Age 1 year
3. Presence of respiratory failure with fractional inspired oxygen (FiO2) 0.4 to achieve an arterial oxygen saturation (SaO2) of 96-99%.
Participants - exclusion criteriaInfants with bronchopulmonary dysplasia (BPD), congenital cardiac, pulmonary or neuromuscular diseases or signs of upper airway obstruction were excluded.
Patient information material
Anticipated start date01/01/2004
Anticipated end date31/12/2004
Status of trialCompleted
Target number of participants42
InterventionsInfants were randomised to either standard treatment, or standard with CNEP.
Inspired oxygen requirement was measured with a calibrated oxygen analyser placed close to the infant's nose in a headbox, in which the oxygen flow was adjusted to maintain SaO2 96-99% at rest, measured with a Nellcor N-200 pulse oximeter.
When an infant fulfilled the entry criteria, written informed consent was obtained from parents and baseline data was collected.
Patients were then randomised to either conventional therapy or conventional therapy plus CNEP. The randomisation was performed using a stratification scheme to achieve a measure of balance in the treatment groups.
Conventional therapy in these hospitals included the use of additional inspired oxygen and bronchodilators. Infants were intubated and positive pressure ventilation (PPV) was initiated in the presence of respiratory acidosis with a pH below 7.25, hypercapnia, hypoxaemia in spite of additional inspired oxygen, recurrent apnoea and respiratory fatigue.
CNEP was applied using purpose built systems (Horner and Wells Ltd, Chelmsford, UK, and DHB Tools Ltd, Leamington Spa, UK).
Treatment was begun with -4 cmH2O of CNEP. If the FiO2 required to achieve normal SaO2 did not decrease within the next 30 min, CNEP was decreased to -6 cmH2O. Weaning from CNEP was attempted after a treatment period of at least 24 hours and usually in the presence of an FiO2<0.3.
Infants were fed by either nasogastric tube, or intravenously, according to the degree of respiratory distress.
Heart rate, respiratory rate and FiO2 were recorded hourly if the infants were at rest when they were treated with additional inspired oxygen.
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingNorth Staffordshire and Royal Berkshire Hospitals
Sponsor nameUniversity Hospital of North Staffordshire (UK)
Sponsor detailsNewcastle Road
Stoke on Trent
United Kingdom
ST4 6QG
Sponsor telephone+44 (0)1782 552832
Sponsor fax+44 (0)1782 713946
Sponsor emailinfo@uhns.nhs.uk
Sponsor websitehttp://www.uhns.nhs.uk
Contact nameDr Martin Samuels
Contact detailsAcademic Department of Paediatrics, University Hospital of North Staffordshire
Stoke on Trent
United Kingdom
ST4 6QG
Contact telephone+44 (0)1782 552832
Contact fax+44 (0)1782 713946
Contact emailsamuels@doctors.org.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN53796751
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central